(Q50977436)

26 March 2018

title

Genetic association between APOA1 and APOD polymorphisms and Alzheimer's disease in a Japanese population. (English)

1 reference

26 March 2018

1 reference

11

Heii Arai

1 reference

26 March 2018

author name string

Nobuto Shibata

1

1 reference

26 March 2018

Tomoyuki Nagata

2

1 reference

26 March 2018

Shunichiro Shinagawa

3

1 reference

26 March 2018

Tohru Ohnuma

4

1 reference

26 March 2018

Hiromi Shimazaki

5

1 reference

26 March 2018

Miwa Komatsu

6

1 reference

26 March 2018

Bolati Kuerban

7

1 reference

26 March 2018

Katrin Tomson

8

1 reference

26 March 2018

Kazuhiko Nakayama

9

1 reference

26 March 2018

Hisashi Yamada

10

1 reference

26 March 2018

publication date

21 May 2013

1 reference

26 March 2018

Journal of Neural Transmission

published in

1 reference

26 March 2018

volume

120

1 reference

26 March 2018

issue

11

1 reference

26 March 2018

page(s)

1599-1603

1 reference

26 March 2018

https://scigraph.springernature.com/pub.10.1007/s00702-013-1036-7

exact match

0 references

cites work

Association between polymorphisms in the apolipoprotein D gene and sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1036-7

Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1036-7

Hippocampal apolipoprotein D level depends on Braak stage and APOE genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1036-7

An apolipoprotein A-I gene promoter polymorphism associated with cognitive decline, but not with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1036-7

Genetic variation in apolipoprotein D and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1036-7

Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A beta aggregation and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1036-7

Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1036-7

Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1036-7

Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1036-7

Human ApoD, an apolipoprotein up-regulated in neurodegenerative diseases, extends lifespan and increases stress resistance in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1036-7

Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1036-7

Human apolipoprotein A-I binds amyloid-beta and prevents Abeta-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1036-7

Polymorphism in apoA1 Influences High-Density Lipoprotein Cholesterol Levels but Is Not a Major Risk Factor of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1036-7

Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1036-7

APOA1 polymorphism influences risk for early-onset nonfamiliar AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1036-7

Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1036-7

Apolipoprotein E genotyping by one-stage PCR

21 January 2018

1 reference

12 December 2020

Gender differences in apolipoprotein D expression during aging and in Alzheimer disease

1 reference

12 December 2020

Amyloid-β25-35 induces apolipoprotein D Synthesis and growth arrest in HT22 hippocampal cells.

1 reference

12 December 2020

Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype

1 reference

12 December 2020

10.1007/S00702-013-1036-7

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018